
85% of Trials Are Delayed Before a Single Patient — Here's the Fix
Episode 39
Steven Thompson on AI, Clinical Trial Activation & Why 85% of Trials Are Delayed | Pharma Prescribed Steven Thompson — founder of Next Trial AI — joins Adam Walker to explain why 85% of clinical trials are delayed before a single patient is enrolled, and what he's building to fix it. Steven spent two decades in high-stakes regulatory environments: first with American Airlines on FAA compliance, then with Embraer in Brazil, then building data engineering pipelines for oncology and vaccines at Biogen and Takeda. When his father died of cancer — after going through an informed consent process based on static eligibility data that couldn't predict whether he'd even tolerate the trial — it became personal. Now, from his base in Brazil, Steven is building the infrastructure that makes clinical trials predictable. Trial ready in 30 days. Zero rejection packets. AI that is provably right — not probably right.
Publisher
Adam Walker’s Pharma Prescribed Podcast
Link
pharmaprescribed.podbean.com/e/pharma-prescribed-with-steven-thompson-from-chaos-to-clarity-ais-quest-to-reshape-clinical-trials/
Published
April 27, 2026
Duration
34 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Adam Walker
Adam Walker’s Pharma Prescribed Podcast
@adamwalkerspharmaprescribedp
#trials #delayed #singlepatient #lifesciences #management
